Follow us on
Nov 05, 2018
Nicolas Thomä's group at the FMI has joined forces with the group of Benjamin Ebert at Harvard’s Broad Institute to show how thalidomide analogs mediate degradation of many more proteins than previously anticipated. These proteins – zinc finger transcription factors – play a role in cancer and developmental diseases but are difficult drug targets. The new study, published in Science, suggests that thalidomide analogs can be rationally designed to target this challenging class of proteins. Read more
Oct 23, 2018
Oct 09, 2018
Oct 05, 2018
Nov 15, 2018. Time: 17:15 FMI Room 530 
Balancing nuclear RNA levels
Torben Jensen, Institute of Molecular Biology and Genetics, Aarhus University, Denmark
Nov 16, 2018. Time: 10:15 FMI Room 530
Epigenome maintenance in response to DNA damage
Sophie Polo, Université Paris Diderot, Paris, France
Nov 16, 2018. Time: 13:00 FMI Room 530
Computational Neuroscience Initiative Basel
Part 1 - Scientific Talk:
Robust coding with spiking neural networks
Part 2 - Workshop:
Spikes - and the headaches they have caused
Christian Machens, Champalimaud Centre for the Unknown, Lisbon, Portugal
More information
Nov 19, 2018. Time: 13:00 FMI Room 530
The role of the testis specific H3 variant H3t in mouse spermatogenesis
Philipp Bammer
da Silveira Dos Santos AX, Liberali P From single cells to tissue self-organization. FEBS J. 2018 Nov 3
Sievers QL, Petzold G, Bunker RD, Renneville A, Slabicki M, Liddicoat BJ, Abdulrahman W, Mikkelsen T, Ebert BL, Thomä NH Defining the human C2H2 zinc finger degrome targeted by thalidomide analogs through CRBN. Science. 2018 Nov 2;362(6414)
Ferreira-Pinto MJ, Ruder L, Capelli P, Arber S Connecting Circuits for Supraspinal Control of Locomotion. Neuron. 2018 Oct 24;100(2):361-374
Keller GB, Mrsic-Flogel TD Predictive Processing: A Canonical Cortical Computation. Neuron. 2018 Oct 24;100(2):424-435
|
Georg Keller (Neurobiology) |
Prisca Liberali (Quantitative Biology) |
